Pharmaneek Pharmacy Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Pharmaneek Pharmacy's estimated annual revenue is currently $7.6M per year.(i)
  • Pharmaneek Pharmacy's estimated revenue per employee is $201,000

Employee Data

  • Pharmaneek Pharmacy has 38 Employees.(i)
  • Pharmaneek Pharmacy grew their employee count by 6% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.6M230%N/AN/A
#2
$23.5M117-28%N/AN/A
#3
$575.7M28642%N/AN/A
#4
$1.8M18-10%$1.5MN/A
#5
$5.8M29-6%N/AN/A
#6
$10.7M5315%N/AN/A
#7
$271.4M13504%N/AN/A
#8
$9.2M4610%N/AN/A
#9
$27760M443974%N/AN/A
#10
$1.2M6-54%N/AN/A
Add Company

What Is Pharmaneek Pharmacy?

Pharmaneek Pharmacy provides specialized services to patients with individual needs. The standard of service provided to patients and the facilities that care for them go far beyond a retail pharmacy. These specialized services keep patients healthier, safer, and help payers control pharmaceutical costs. Pharmaneek's programs revolve around the following: Compliance Pharmaneek's UneekDoseâ„¢ makes it easier for patients to remember to take their medications correctly by pre-sorting them and packaging them in easy-to-use single dose packets. Convenience FREE HOME DELIVERY save time & money on gas and medicines. PROACTIVE REFILL MANAGEMENT manages your refills and follow up with doctors to get new prescriptions or prior authorization Confidence Pharmaneek assures Medical Professional that the medications they prescribe are taken as intended. Independence People with multiple prescriptions can now focus on other important issues in their life. Pharmaneek provides them with simplified and error-free MEDICATION MANAGEMENT.

keywords:N/A

N/A

Total Funding

38

Number of Employees

$7.6M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.8M383%N/A
#2
$7.3M3812%N/A
#3
$5.5M3852%N/A
#4
$8.2M3823%N/A
#5
$6.1M386%N/A